[Interview] Ultra V/ Dermaster Clinic Netowrk Representative Kwon Han-Jin CEO

Ultracol completed product certification permission in Hainan Province, China

Biological safety evaluation for entry into mainland China is in progress 

We met with Kwon Jin, CEO of Ultra V, which won the IR52 Jang Young-sil Award and the Korea Patent Grand Prize in 2020 in recognition of its excellence in the world's first PDO (Polydioxanone) material filler manufacturing and mass production technology.

Ultra V, which has KFDA certification from the Ministry of Food and Drug Safety and CE certification from Europe, and has received Hainan Province certification and official approval from China's NMPA in 2023, is receiving a lot of attention in domestic and overseas markets.

 Ultra V CEO/ Dermaster clinic network CEO director Kwon Hanji

Q. Please introduce biomedical beauty group Ultra V and yourself

Hello. This is Kwon Jin Kwon, CEO of Ultra V and CEO of Dermaster Clinic Network. Ultra V is a global biomedical beauty group that exports and sells to over 60 countries around the world and is engaged in a business that combines cosmetics and medical. In particular, it can be said to be a representative company that promoted K-beauty through absorbable lifting thread and ULTRACOL.

Our main business is manufacturing and selling cosmetics, medical supplies, and medical devices. Ultra V wants to help you maintain your natural beauty.

Q. You founded the company in 2012. What was the reason?

General lasers and devices made and sold by equipment companies have caused many 

inconveniences when I actually used in the field. After thinking about whether further 

improvements would be more convenient for doctors and benefit patients, I became 

interested in the business to narrow the gap.

In the meantime, we registered a patent and trademark ‘Ultra V Lifting’ for absorbable threadand established Ultra V in earnest. To this day, we are manufacturing and selling 

various cosmetic products, laser equipment, absorbable thread, skin booster and Ultracol.

Q. What are Ultra V’s consistent best-selling products?

Ultracol is a booster that induces autologous collagen production. This product was created through the development of Ultra V's proprietary technology. It injects PDO (Polydioxanone), which is harmless to the human body, into the skin in the form of small microspheres to help natural collagen production, improve wrinkles and elasticity, as well as improve difficult eyesight. This is a product that can improve problems such as sagging skin, dark circles, nasolabial folds, facial pores and skin texture.

Q. Each filler manufacturer has different product characteristics, but what are the advantages of ‘Ultracol’?

Above all, unlike filler injection products filled with artificial ingredients, its strength is that it naturally induces self-collagen production to fill out volume while also providing skin 

improvement effects.

In addition, PDO, the main ingredient, is a soluble thread ingredient used for suturing threads or thread lifting during surgery, and is safer because it naturally dissolves and is absorbed in the body. Meanwhile, Ultracol is characterized by the round sphere shape of fine particles so it does not cause foreign body sensation even when applied to areas of thin skin and the occurrence of nodules and granulomas is very low which are side effects of other filler products. It also absorbs and disappears after a few months. Therefore, it is possible for a more natural and safer procedure.

Q. Forecast on future filler trends?

In the past, local procedures that improved only specific areas such as the nose, nasolabial folds, and under the eyes were common, but recently, the number of procedures performed to achieve harmony and balance of the entire face is increasing. There is a trend of increasing satisfaction with the treatment as it fills in lost areas with appropriate volume and improves skin texture, tone, pores, and elasticity at the same time.

Ultracol is a product specialized for collagen regeneration and volume improvement, and can be used not only on the face but also on various other areas that cannot be performed with existing fillers.

In addition, products in the domestic filler market are mainly overseas products or domestic products that are copies of overseas products. Among them, Ultracol is the only product in the world and is expected to further spread the reputation of K-beauty in overseas markets by Korean technology and products in the beauty medical market.

Q. I heard that Ultracol recently obtained product certification in China. What are the local reactions and future overseas market goals?

Last December, product certification approval was completed in Hainan Province, China, and a biological safety evaluation is in progress for entry into mainland China this year. Based on this, we plan to submit a clinical trial within 3 months, and upon completion of the clinical trial, we expect to be able to sell Ultracol in mainland China.

In addition, we are in the process of registering ANVISA products for sale in Brazil this year and are expected to receive product approval in June. We will begin selling the product as soon as this process is complete.

Q. CEO Kwon Hanjin is also an doctor. Is there anything you would like to offer to 

those who have concerns about skin care?

The most important thing in recent cosmetic surgery trends is safety. Choosing safe product is of the utmost importance and the trend is emphasizing naturalness. Ultra V is developing safe and natural products that reflect these consumer needs and is currently exporting to overseas markets such as Korea and China. 

​